EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Probing the Biological Plausibility of Fluoride as an Endocrine Disruptor

Ashley M Mudd iD, Bladimir J Ovando iD, George P Daston iD

Birth Defects Research · 2026-05 · 118 (5)

DOI: 10.1002/bdr2.70046 ↗

At a glance

Journal article in Birth Defects Research, published online on 2026-05-15. Written by Ashley M Mudd and 2 co-authors. Institution: Procter & Gamble, Central Product Safety, Mason, Ohio, USA. Major MEDLINE topics: Endocrine Disruptors, Fluorides, Sodium Fluoride. 46 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Procter & Gamble.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Fluoride has come under recent scrutiny regarding concerns over potential neurodevelopmental and endocrine‐related toxicities, with recent reviews by the National Toxicology Program (NTP) and European Food Safety Authority (EFSA) concluding with moderate or reasonable confidence, respectively, that exposure to drinking water having greater than 1.5 mg fluoride/L is associated with lower IQ in children. A key outcome of these reviews is the uncertainty regarding the biological plausibility of these findings. However, it has been hypothesized that endocrine disruption could be a potential factor.

Methods

To determine if sodium fluoride exerts direct biological activity on molecular and cellular targets related to endocrine disruption, receptor binding and activity assays of thyroid and other hormone‐related targets, H295R steroidogenesis, and sodium‐iodide symporter (NIS) assays were carried out using exposures comparable to or in excess of those that have been reported to be associated with neurodevelopmental outcomes and other effects.

Results

Sodium fluoride at up to 316 μM NaF did not affect synthesis of estrogen or testosterone. Sodium fluoride at up to 10 μM NaF did not interact with aromatase, steroid 5 alpha‐reductase, estrogen receptors, androgen receptors, thyroid hormone receptors, nor did it inhibit thyroid peroxidase. Furthermore, there were no changes in iodide uptake via symporter transport (up to 300 μM NaF). Other endocrine targets were also evaluated at 10 μM NaF, including PR, PPARα, PPARγ, AhR, CAR, PXR, RARα, or GR, and no binding was observed either.

Conclusions

Together, the results from this series of experiments demonstrate an absence of effects of fluoride on endocrine disruption targets at concentrations comparable to or in excess of exposures reported in the literature to be associated with neurodevelopmental outcomes and other effects.

Subjects

MeSH terms (MEDLINE)

Endocrine DisruptorsFluoridesSodium FluorideHumansThyroid GlandAnimalsSodium-Iodide SymportersSymporters

Author keywords

endocrine disruptionfluoridethyroidtoxicity

Substances

Endocrine DisruptorsFluoridesSodium FluorideSodium-Iodide SymportersSymporters

Authors and institutions

  • Procter & Gamble, Central Product Safety, Mason, Ohio, USA.

ORCID profiles: Ashley M Mudd, Bladimir J Ovando, George P Daston

Funding

  • Procter & Gamble

Cite

APA

Mudd, A. M., Ovando, B. J., & Daston, G. P. (2026). Probing the Biological Plausibility of Fluoride as an Endocrine Disruptor. Birth Defects Research, 118(5). https://doi.org/10.1002/bdr2.70046

Vancouver

Mudd AM, Ovando BJ, Daston GP. Probing the Biological Plausibility of Fluoride as an Endocrine Disruptor. Birth Defects Research. 2026;118(5). doi:10.1002/bdr2.70046

BibTeX
@article{Mudd2026,
  author = {Mudd, Ashley M and Ovando, Bladimir J and Daston, George P},
  title = {Probing the Biological Plausibility of Fluoride as an Endocrine Disruptor},
  journal = {Birth Defects Research},
  year = {2026},
  volume = {118},
  number = {5},
  doi = {10.1002/bdr2.70046}
}
Start for free →